CG Oncology, Inc. (CGON) Reports Q3 Loss of $0.57

CG Oncology, Inc. (NASDAQ: CGON) reported Q3 EPS of ($0.57). Revenue for the quarter came in at $1.67 million versus the consensus estimate of $20 thousand.

For earnings history and earnings-related data on CG Oncology, Inc. (CGON) click here.

You May Also Be Interested In

• Saudi Arabia Oil Pipeline Struck By Projectiles Thursday - CNN
• Dell shares surge on record AI server bookings
• QatarEnergy trading seeks 2-3M tons per annum of LNG through 2031 as Ras Laffan repairs are seen raking 3-5 years - Reuters